Stockscreener 앱 받기
4.23
7.64%
-0.35
시간 외 거래:
4.34
0.11
+2.60%
전일 마감가:
$4.58
열려 있는:
$4.51
하루 거래량:
1.36M
Relative Volume:
0.35
시가총액:
$48.26M
수익:
$32.77M
순이익/손실:
$-101.98M
주가수익비율:
-0.4402
EPS:
-9.6101
순현금흐름:
$-112.43M
1주 성능:
+51.07%
1개월 성능:
+132.42%
6개월 성능:
-61.84%
1년 성능:
-79.86%
1일 변동 폭
$4.22
$4.83
1주일 범위
$2.71
$4.83
52주 변동 폭
$1.35
$26.83
X 4 Pharmaceuticals Inc Stock (XFOR) Company Profile
명칭
X 4 Pharmaceuticals Inc
전화
857-529-8300
주소
61 NORTH BEACON STREET, BOSTON, MA
XFOR을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
XFOR
X 4 Pharmaceuticals Inc
|
4.23 | 102.82M | 32.77M | -101.98M | -112.43M | -9.6101 |
|
VRTX
Vertex Pharmaceuticals Inc
|
389.08 | 99.27B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
586.96 | 62.28B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
454.18 | 59.14B | 2.46B | -319.09M | -52.09M | -2.47 |
|
ARGX
Argen X Se Adr
|
707.96 | 43.34B | 3.06B | 1.28B | 447.35M | 21.30 |
|
ONC
Beone Medicines Ltd Adr
|
300.14 | 36.72B | 3.81B | -644.79M | -669.77M | -6.24 |
X 4 Pharmaceuticals Inc Stock (XFOR) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2023-12-12 | 다운그레이드 | B. Riley Securities | Buy → Neutral |
| 2023-08-30 | 재개 | B. Riley Securities | Buy |
| 2022-12-22 | 개시 | Cantor Fitzgerald | Overweight |
| 2022-12-12 | 개시 | Piper Sandler | Overweight |
| 2019-12-23 | 개시 | Oppenheimer | Outperform |
| 2019-12-18 | 개시 | ROTH Capital | Buy |
| 2019-12-09 | 업그레이드 | Citigroup | Neutral → Buy |
| 2019-12-05 | 개시 | B. Riley FBR | Buy |
| 2019-06-07 | 개시 | Stifel | Buy |
| 2019-06-05 | 개시 | Cowen | Outperform |
모두보기
X 4 Pharmaceuticals Inc 주식(XFOR)의 최신 뉴스
Sector Rotation Brings X4 Pharmaceuticals Inc. Into Focus2025 Bull vs Bear & AI Forecast for Swing Trade Picks - sundaytimes.kr
Forecasting X4 Pharmaceuticals Inc. price range with options data2025 Dividend Review & Real-Time Volume Analysis Alerts - Newser
Has X4 Pharmaceuticals Inc. formed a bullish divergencePortfolio Update Report & Weekly Breakout Opportunity Watchlist - Newser
Trend analysis for X4 Pharmaceuticals Inc. this week2025 Top Gainers & Fast Moving Stock Trade Plans - Newser
Price momentum metrics for X4 Pharmaceuticals Inc. explainedTrade Risk Assessment & AI Based Buy/Sell Signal Reports - Newser
Will X4 Pharmaceuticals Inc. continue its uptrendShort Setup & Smart Money Movement Alerts - Newser
Multi asset correlation models including X4 Pharmaceuticals Inc.July 2025 Review & Free Technical Pattern Based Buy Signals - Newser
What Fibonacci levels say about X4 Pharmaceuticals Inc. rebound2025 Bull vs Bear & Smart Allocation Stock Reports - Newser
Intraday pattern recognizer results for X4 Pharmaceuticals Inc.Market Movers & Low Drawdown Momentum Ideas - Newser
X4 Pharmaceuticals announces board resignations and audit committee appointments - Investing.com
X4 Pharmaceuticals Announces Board Resignations and Appointments - TipRanks
Why X4 Pharmaceuticals Inc. stock attracts strong analyst attentionTreasury Yields & AI Forecasted Stock Moves - Newser
Using data tools to time your X4 Pharmaceuticals Inc. exitWeekly Stock Recap & Scalable Portfolio Growth Ideas - Newser
Real time breakdown of X4 Pharmaceuticals Inc. stock performance2025 Analyst Calls & Weekly Watchlist of Top Performers - Newser
Is X4 Pharmaceuticals Inc. stock a value trapChart Signals & Advanced Technical Analysis Signals - theviewers.co.kr
Quant Models Detect Momentum Reversal in X4 Pharmaceuticals Inc.July 2025 Analyst Calls & Verified Momentum Stock Alerts - beatles.ru
Reversal indicators forming on X4 Pharmaceuticals Inc. stockPortfolio Growth Summary & Community Shared Stock Ideas - Newser
X4 Pharmaceuticals Inc. Stocks Attracting Dip BuyersJuly 2025 Chart Watch & Stock Market Timing Techniques - mustnews.co.kr
Can X4 Pharmaceuticals Inc. Escape Recent Bear ChannelJuly 2025 Trade Ideas & Daily Stock Trend Watchlist - newsyoung.net
Can swing trading help recover from X4 Pharmaceuticals Inc. lossesGap Down & Weekly Market Pulse Updates - Newser
Is X4 Pharmaceuticals Inc. stock entering bullish territoryMarket Performance Report & Low Drawdown Momentum Trade Ideas - Newser
Combining price and volume data for X4 Pharmaceuticals Inc.Trade Entry Summary & Weekly Watchlist of Top Performers - Newser
Using Bollinger Bands to evaluate X4 Pharmaceuticals Inc.Dollar Strength & Community Driven Trade Alerts - Newser
Is X4 Pharmaceuticals Inc. Forming a Bottom PatternJuly 2025 Snapshot & Weekly Market Pulse Updates - newsimpact.co.kr
Published on: 2025-08-18 06:28:48 - Newser
Published on: 2025-08-18 04:45:24 - Newser
Will X4 Pharmaceuticals Inc. benefit from macro trendsTrade Analysis Report & Low Drawdown Trading Strategies - Newser
Momentum divergence signals in X4 Pharmaceuticals Inc. chartJuly 2025 Analyst Calls & Daily Technical Forecast Reports - Newser
X 4 Pharmaceuticals Inc (XFOR) 재무 분석
매출
순이익
현금흐름
주당 순 이익
X 4 Pharmaceuticals Inc 주식 (XFOR) 내부자 거래
| 내부자 거래 | 관계 | 날짜 | 거래 | 비용 | #주식 | 가치 ($) | #주식 총계 |
|---|---|---|---|---|---|---|---|
| Baldry Mark | Chief Commercial Officer |
Nov 15 '24 |
Buy |
0.34 |
13,404 |
4,598 |
129,173 |
| Ragan Paula | President and CEO |
Jan 24 '25 |
Sale |
0.45 |
76,473 |
34,719 |
1,087,386 |
| Mostafa Adam S. | Chief Financial Officer |
Jan 24 '25 |
Sale |
0.45 |
74,773 |
33,947 |
0 |
| Baldry Mark | Chief Commercial Officer |
Jan 24 '25 |
Sale |
0.45 |
29,159 |
13,241 |
94,123 |
| DiBiase Mary | Chief Operating Officer |
Jan 24 '25 |
Sale |
0.45 |
22,258 |
10,094 |
490,980 |
| Arbet-Engels Christophe | Chief Medical Officer |
Jan 24 '25 |
Sale |
0.45 |
11,624 |
5,284 |
14,207 |
0.98%
8.06%
자본화:
|
볼륨(24시간):